Cullinan Therapeutics (CGEM) Current Leases (2022 - 2023)

Historic Current Leases for Cullinan Therapeutics (CGEM) over the last 2 years, with Q3 2023 value amounting to $1.5 million.

  • Cullinan Therapeutics' Current Leases rose 12227.01% to $1.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.5 million, marking a year-over-year increase of 12227.01%. This contributed to the annual value of $1.4 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Cullinan Therapeutics reported Current Leases of $1.5 million as of Q3 2023, which was up 12227.01% from $1.7 million recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Current Leases high stood at $1.7 million for Q2 2023, and its period low was $519000.0 during Q1 2022.